AIM IMMUNOTECH INC (AIM)
AMEXHealth CareBiotechnologySnapshot 2026-09-04
$0.23-2.61%
Close 2026-09-04 · 1-day change
AMEXHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · AIM
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 | 0.1 | 0.4 | 0.4 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 |
| Total Revenues | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 | — | — | — | 0.4 | 0.4 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 |
| Cost of Revenues | — | — | — | — | — | — | — | — | — | — | — | — | 1.3 | 1.2 | 2.0 | 1.0 |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | 2.7 | 3.9 | 6.2 | 10.9 | 7.0 | 7.7 | 5.7 | 4.7 | 4.8 | 4.1 | 5.1 | 8.0 | 9.0 | 8.4 | 9.5 | 6.7 |
| Operating Income | (11.1) | (11.7) | (19.8) | (31.9) | (19.9) | (18.8) | (15.2) | (12.4) | (11.5) | (11.4) | (13.8) | (16.7) | (19.1) | (17.2) | (20.3) | (14.3) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | 1.1 | 0.8 | 0.6 | — | — | 0.1 | 0.7 | — | 0.2 | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Asset Writedown | — | — | — | — | — | 1.8 | 0.1 | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | — | (14.0) | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | ||||||||||||||||
| Net Income | (14.3) | (14.0) | (17.3) | (29.0) | (19.4) | (19.1) | (14.4) | (9.4) | (9.8) | (8.3) | (7.5) | (15.2) | (17.5) | (16.2) | (17.4) | (9.0) |
| Per Share | ||||||||||||||||
| Basic EPS | (0.83) | (8.62) | (0.31) | (0.60) | (0.40) | (0.40) | — | — | — | — | — | — | — | — | — | — |
| Diluted EPS | (0.83) | (8.62) | (0.31) | (0.60) | (0.40) | — | — | — | — | — | — | — | — | — | — | — |
| Revenue per Share | 0.01 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 17.1 | 1.6 | 56.0 | 48.6 | — | — | — | — | — | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 17.1 | 1.6 | 56.0 | 48.6 | 48.0 | — | — | — | — | — | — | — | — | — | — | — |
| Supplemental | ||||||||||||||||
| EBIT | (11.1) | (11.7) | (19.8) | (31.9) | (19.9) | (18.8) | (15.2) | (12.4) | (11.5) | (11.4) | (13.8) | (16.7) | (19.1) | (17.2) | (20.3) | (14.3) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.